A Phase III randomized study of interleukin‐2 lymphokine‐activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma
Open Access
- 1 July 1997
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: